Literature DB >> 9875634

Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma.

M S De Mitri1, L Mele, C H Chen, A Piccinini, R Chianese, A D'Errico, A Alberti, E Pisi.   

Abstract

BACKGROUND/AIMS: The hepatitis C virus (HCV) genome consists of quasispecies populations of heterogeneous variants, especially in the hypervariable region. To assess the profiles of viral quasispecies in HCV-related hepatocellular carcinoma, we studied the viral population patterns in serum and liver tissues of 13 HCV-positive patients with hepatocellular carcinoma developed on cirrhotic and non-cirrhotic livers (5 and 8 cases, respectively).
METHODS: HCV genome heterogeneity was analyzed by polymerase chain reaction-mediated single-strand conformation polymorphism analysis, which showed multiple DNA bands representing different hypervariable region sequences.
RESULTS: The HCV populations were different between tumorous and nontumorous tissues in 3/5 hepatocellular carcinomas with cirrhosis and in 6/8 without cirrhosis. At least one or more than one common band was detected in both compartments in all but one case. No significant differences in the complexity of HCV quasispecies were found in hepatocellular carcinoma with or without underlying cirrhosis. Comparison of the HCV quasispecies profiles in serum and liver tissues showed a different distribution of HCV variants between these two compartments in 6/7 patients. In four cases, both common and compartmentalized sequences were detected, whereas in two cases, both without cirrhosis, the HCV population in serum was completely different from that found in the liver.
CONCLUSIONS: These results suggest that the complexity of HCV populations is influenced by the presence of hepatocellular carcinoma rather than by the severity of the underlying chronic liver disease. The different quasispecies patterns found in serum and liver may reflect different biological properties of circulating and intrahepatic HCV particles or the existence of extrahepatic sites of replication.

Entities:  

Mesh:

Year:  1998        PMID: 9875634     DOI: 10.1016/s0168-8278(98)80115-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.

Authors:  Brent Korba; Kirti Shetty; Alexei Medvedev; Prasanth Viswanathan; Rency Varghese; Bin Zhou; Rabindra Roy; Kepher Makambi; Habtom Ressom; Christopher A Loffredo
Journal:  J Gen Virol       Date:  2015-07-03       Impact factor: 3.891

2.  The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma.

Authors:  Xiaoan Zhang; Soo Hyung Ryu; Yanjuan Xu; Tamerl Elbaz; Abdel-Rahman N Zekri; Ashraf Omar Abdelaziz; Mohamed Abdel-Hamid; Valerie Thiers; Santiago F Elena; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  J Clin Virol       Date:  2011-09-17       Impact factor: 3.168

3.  Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Authors:  Hui Li; Daniel G Sullivan; Nathan Feuerborn; Susan McArdle; Kirubeal Bekele; Sampa Pal; Matthew Yeh; Robert L Carithers; James D Perkins; David R Gretch
Journal:  Virology       Date:  2010-04-18       Impact factor: 3.616

Review 4.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.

Authors:  Ahmed A Al-Qahtani; George Kessie; Damian Dela Cruz; Faleh Z Al-Faleh; Mohammed N Al-Ahdal
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

6.  Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma.

Authors:  Sarah L Fishman; Stephanie H Factor; Cinzia Balestrieri; Xiaofeng Fan; Adrian M Dibisceglie; Suresh M Desai; Gary Benson; Andrea D Branch
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

7.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.